15 December 2023 - The Biden Administration said on Thursday it had identified 48 drugs in the Medicare program whose prices rose quicker than inflation during the fourth quarter of the year and may require their makers to pay rebates.
President Joe Biden's signature Inflation Reduction Act includes a provision to penalise drug makers who work with Medicare, a government program for people aged 65 and older or who are disabled.